After teaching a patient who is prescribed adalimumab (Humira) for severe ulcerative colitis, the nurse assesses the patient's understanding. Which statement made by the patient indicates a need for additional teaching?

"I will take this medication with my breakfast each morning."

Explanation:

Adalimumab (Humira) is an immune modulator that must be administrated via subcutaneous injection. It can't be given with food or milk. Some of the most common side effects of this injection are nausea and vomiting. Adalimumab is known for causing immune suppression, so the people who are receiving the injection should avoid large crowds and people who are sick, and should wash their hand very thoroughly.